Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.55 | N/A |
| PEG Ratio (TTM) | -1.05 | N/A |
| P/S Ratio (TTM) | 1.49 | N/A |
| P/B Ratio (TTM) | 2.28 | N/A |
| P/FCF Ratio (TTM) | -152.11 | N/A |
| Price to 5YR AVG Earnings Ratio | 25.17 | N/A |
| Price to 5YR AVG FCF Ratio | 56.51 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.93% | N/A |
| ROE (TTM) | 7.80% | N/A |
| Net Profit Margin (TTM) | 4.56% | N/A |
| ROIC 5YR AVG | 10.04% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -28.29% | 28.79% | 26.68% |
| Revenue | -3.44% | 22.23% | 20.49% |
| Net Income | -26.61% | 28.82% | 28.57% |
| Cash Flow | 169.87% | 247.57% | 123.62% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.08 | N/A |
| Quick Ratio (TTM) | 1.71 | N/A |
| D/E Ratio (TTM) | 0.96 | N/A |
| Interest Coverage (TTM) | 3.18 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.92 | N/A |
| LTL to 5YR AVG FCF | 24.14 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.05% | N/A |